Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
InnoCare Pharma Ltd. (HK:9969)
HKEX:9969
Holding HK:9969?
Track your performance easily
See the Price Targets and Ratings of:
9969 Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
9969 Stock 12 Month Forecast
Average Price Target
HK$8.80
▲(25.18% Upside)
| Highest Price TargetHK$8.80 | Average Price TargetHK$8.80 | Lowest Price TargetHK$8.80 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
Reiterated
10/25/24
UBS
HK$12.6→HK$11.6
Buy
65.01%
Upside
Reiterated
11/14/23
InnoCare Pharma Limited (9969:HK) (INCPF) PT Lowered to HK$11.60 at UBSUBS analyst Chen Chen lowered the price target on InnoCare Pharma Limited (9969:HK) (OTC: INCPF) to HK$11.60 (from HK$12.60) while maintaining a Buy rating.
Best Analysts Covering InnoCare Pharma Ltd.
Which Analyst Should I Follow If I Want to Buy HK:9969 and Sell After:
1 Month
xxx
Success Rate
1/3 ratings generated profit
Average Return
+3.43%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of +3.43% per trade.
3 Months
xxx
Success Rate
1/3 ratings generated profit
Average Return
+4.33%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +4.33% per trade.
1 Year
2 Years
xxx
Success Rate
1/3 ratings generated profit
Average Return
+4.47%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +4.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
9969 Analyst Recommendation Trends
Rating
May 23
Aug 23
Nov 23
Sep 24
Oct 24
Strong Buy
2
2
2
2
2
Buy
0
1
1
1
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
9969 Financial Forecast
9969 Stock Forecast FAQ
What is HK:9969’s average 12-month price target, according to analysts?
Based on analyst ratings, InnoCare Pharma Ltd.’s 12-month average price target is HK$8.80.
What is HK:9969’s upside potential, based on the analysts’ average price target?
InnoCare Pharma Ltd. has 25.18% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is InnoCare Pharma Ltd. a Buy, Sell or Hold?
InnoCare Pharma Ltd. has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is InnoCare Pharma Ltd.’s share price target?
The average share price target for InnoCare Pharma Ltd. is HK$8.80. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$8.80 ,and the lowest forecast is HK$8.80. The average share price target represents 25.18% Increase from the current price of HK$7.03.
The highest analyst share price target is HK$8.80 ,and the lowest forecast is HK$8.80. The average share price target represents 25.18% Increase from the current price of HK$7.03.
What do analysts say about InnoCare Pharma Ltd.?
InnoCare Pharma Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of InnoCare Pharma Ltd.?
To buy shares of HK:9969, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.